A review of dengue research in Malaysia

Medical Journal of Malaysia

Volumn 69, Issue , 2014, Pages 59-67

  Cheah, Wee Kooi ^a   Ng, Kee Sing ^b   Marzilawati, Abdul Rahman ^b   Lum, Lucy Chai See ^c  

^a Hospital Taiping   (Malaysia)

^b HOSPITAL KUALA LUMPUR   (Malaysia)

^c UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Dengue; Diagnosis; Economic burden; Epidemiology; Malaysia; Prevention; Serotypes; Vaccine

Indexed keywords

DENGUE VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ACUTE LIVER FAILURE; ANTIBODY DEPENDENT ENHANCEMENT; CHIKUNGUNYA; DENGUE; DENGUE VIRUS; DISEASE SURVEILLANCE; FEVER; GENOTYPE; HEALTH ECONOMICS; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION CONTROL; LYMPHOCYTE COUNT; MALAYSIA; NEUROLOGIC DISEASE; PHASE 3 CLINICAL TRIAL (TOPIC); PREGNANCY OUTCOME; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY AND SPECIFICITY; SEROTYPE; SKIN DISEASE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTOPENIA; VIRUS LOAD; VIRUS REPLICATION;

EID: 84910646639     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Wallace Hazel G, et al. Dengue haemorthagic fever in Malaysia 1973 epidemic. South East Asian J. Trop. Med. Pub. Health 1980; 11: 1-12.
2. Fang R, Lo E, Lim TW. The 1982 dengue epidemic in Malaysia: epidemiological, serological and virological aspects. Southeast Asian J Trop Med Public Health 1984; 15: 51-8.
3. Malaysia MoH. Clinical Practice Guidelines on Management of Dengue Infection in Adults. (revised 2nd ed)2010.
4. Malaysia MoH. Statement on dengue by director general of health. 2009.
5. Malaysia MoH. Annual report 1974,1980, 1984, 1998, 1999, 2000.
6. Mia MS, Begum RA, Er AC, et al. Trends of dengue infections in Malaysia, 2000-2010. Asian Pac J Trop Med 2013; 6(6): 462-6.
7. Arima Y, Matsui T. Epidemiologic update of dengue in the Western Pacific Region, 2010. Western Pac Surveill Response J 2011; 2(2): 4-8.
8. Arima Y, Edelstein Z, Han HK, et al. Epidemiologic update on the dengue situation in the Western Pacific Region, 2011. Western Pac Surveill Response J 2013; 4(2): 47-54.
9. Chew MH, Rahman MM, Sharifah Azura S. Dengue in Malaysia: An epidemiological perspective stud. Pak J Med Sci 2012; 28(4): 643-7
10. Ahmad Nizal MG, Rozita H, Mazrura S, et al. Dengue infections and circulating serotypes in Negeri Sembilan, Malaysia. Malaysian Journal of Public Health Medicine 2012; 12(1): 21-30.
11. Anker M, Arima Y. Male-female differences in the number of reported incident dengue fever cases in six Asian countries. Western Pac Surveill Response J 2011; 2(2): 17-23.
12. Ooi EE, Gubler DJ. Dengue in Southeast Asia: epidemiological characteristics and strategic challenges in disease prevention. Cad. Saúde Pública, Rio de Janeiro 2008; 25 Sup 1: S115-S124.
13. Nor Azila, MA Sharifah Azura S, Neoh HM, et al. Dengue epidemic in Malaysia: Not a predominantly urban disease anymore. BMC Res Notes 2011; 4(216): 0500-4216.
14. Chen WS, Wong CH, Cillekens L. Dengue antibodies in a suburban community in Malaysia. Med J Malaysia 2003; 58(1): 142-3.
15. Ravindran T, MS, Fatimah S, et al. The role of virological surveillance of dengue serotypes for the prediction of dengue outbreak. Trop Biomed 2001; 18(2): 109-16.
16. Sazaly AB, Wong PF. Re-emergence of Dengue 4 virus. Med J Malaysia 2002; 57(2): 242-3.
17. Vinomarlini G, Rogayah T, Saraswathy TS, et al. Molecular typing of dengue viruses circulating on the East Coast ofPeninsular Malaysia from 2005 to 2009. Southeast Asian J Trop Med Public Health 2011; 42(1): 94-9.
18. Chee HY, Sazaly AB. Phylogenetic investigation of dengue virus type 2 isolated in Malaysia. Dengue Bulletin 2003; 27: 101-7.
19. Holmes EC, Tio PH, Perera D, et al. Importation and co-circulation of multiple serotypes of dengue virus in Sarawak, Malaysia. Virus Res 2009; 143(1): 1-5.
20. Shamala D. Dengue: Breakbone fever, hemorrhagia or shock. JUMMEC 2008; 11(2):39-52.
21. Jessie K Fong MY, Shamala D, KC Sekaran, et al. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 2004; 189(8): 1411-8.
22. MJ. Cardosa. Dengue haemorrhagic fever: questions of pathogenesis. Curr Opin Infect Dis 2000; 13(5): 471-5.
23. Fong MY, Yusup R, Yusof R, et al. Neurovirulence of four encephalitogenic dengue 3 virus strains isolated in Malaysia (1992-1994) is not attributed to their envelope protein. Trans R Soc Trop Med Hyg 2004; 98(6): 379-81
24. Appanna R, Tan LH, Lum LCS, et al. Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia. Clin Vaccine Immunol 2007; 14(8): 969-77.
25. Appanna R, Wang SM, Ponnampalavanar SA, et al. Cytokine factors present in dengue patient sera induces alterations of junctional proteins in human endothelial cells. Am J Trop Med Hyg 2012; 87(5): 936-42.
26. Rathakrishnan A, Wang SM, Hu Y, et al. Cytokine expression profile of dengue patients at different phases of illness. PLoS One 2012; 7(12): e52215.
27. Appanna R, Sasheela P, Lum LCS, et al. Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population. PLoS One 2010; 5(9): 10.1371/journal.pone.0013029.
28. Ooi ET, Ganesananthan S, Anil R, et al. Gastrointestinal manifestations of dengue infection in adults. Med J Malaysia 2008; 63(5): 401-5.
29. S. Fadilah, Sahrir S, Mazlam MZ, et al. A comparison of the pattern of liver involvement in dengue hemorrhagic fever with classic dengue fever. Southeast Asian J Trop Med Public Health 2000; 31(2): 259-63.
30. Norlijah O, Khamisah A, Kamarul A, et al. Serial tourniquet testing in dengue haemorrhagic fever-How clinically useful is it?. Malaysian Journal of Paediatrics and Child Health 2005; 14:27-32.
31. Norlijah O, Khamisah A, Kamarul A, et al. Repeated tourniquet testing as a diagnostic tool in dengue infection. Med J Malaysia 2006; 61(1): 22-7.
32. Rusmawati I, Asma Hanim H, Naznin M, et al. A descriptive study of blood films of patients serologically positive for dengue in Hospital Tengku Ampuan Afzan, Kuantan. International Medical Journal (IIUM) 2010; 9(2): 35-8.
33. Tong SF, Aziz NA, Chin GL. Prevalence of non-dengue thrombocytopaenia among adult patients presenting with acute febrile illness in primary outpatient clinics. Medicine & health 2006; 1(1): 25-30.
34. Tong SF, Aziz NA, Chin GL, et al. Clinical features of acute febrile thrombocytopaenia among patients attending primary care clinics. Malaysian Family Physician 2006; 1(1): 15-8.
35. Tong SF, Aziz NA, Chin GL. Predictive value of thrombocytopaenia in the diagnosis of dengue infection in outpatient settings. Med J Malaysia 2007; 62(5): 390-3.
36. Mustafa B, Hani AW, Chem YK, et al. Epidemiological and clinical features of dengue versus other acute febrile illnesses amongst patients seen at government polyclinics. Med J Malaysia 2010; 65(4): 291-6.
37. Norlijah O, Kamarudin NB, Kamarul AR. Clinico-laboratory profile of dengue haemorrhagic fever in Malaysian children. Asian-Oceanian Journal of Pediatrics and Child Health 2004; 3(2).
38. Breen E et al., Early Predictors of Dengue Infection in Adults (EPOD) - A Malaysian Outpatient Experience, Dengue Bulletin 2012, Vol 36.
39. Mohd Zim MA, Sam IC, Omar SF, et al. Chikungunya infection in Malaysia: comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol 2013; 56(2): 141-5.
40. Tan PC, Wang SM, Lay KS, et al. Dengue infection and miscarriage: a prospective case control study. PLoS Negl Trop Dis 2012; 6(5): e1637.
41. Tan PC, Rajasingam G, Devi S, et al. Dengue infection in pregnancy: prevalence, vertical transmission, and pregnancy outcome. Obstet Gynecol 2008; 111(5): 1111-7
42. Tee HP, How SH, Jamalludin AR, et al. Risk factors associated with development of dengue haemorrhagic fever or dengue shock syndrome in adults in Hospital Tengku Ampuan Afzan Kuantan. Med J Malaysia 2009 64(4): 316-20.
43. Sam SS, Omar SF, Teoh BT, et al. Review of dengue hemorrhagic fever fatal cases seen among adults: a retrospective study. PLoS Negl Trop Dis 2013;7(5):e2194.
44. Tan LH, Lum LC, Omar SF, et al. Hemophagocytosis in dengue: comprehensive report of six cases. J Clin Virol 2012; 55(1): 79-82.
45. Kamil SM, Mohamad NH, Narazah MY, et al. Dengue haemorrhagic fever with unusual prolonged thrombocytopaenia. Singapore Med J 2006; 47(4): 332-4.
46. Rashidi A, Abdul Latiff AK, Salmi AR. Myalgia cruris epidemica: an unusual presentation of dengue fever. Southeast Asian J Trop Med Public Health 2007; 38(6): 1084-7.
47. Umi Kalthum MN, Wong HS. Dengue fever presenting as bilateral dengue maculopathy. Medicine & health 2012; 7(1): 57-61.
48. Tan SY, Kumar G, Surrun SK, et al. Dengue maculopathy: a case report. Travel Med Infect Dis 2007; 5(1): 62-3.
49. J M. K. Murthy, Neurological complications of dengue infection. Neurol India 2010; 58: 581-84.
50. Azmin S, S Ramesh, Suehazlyn Z, et al. Post-dengue parkinsonism. BMC Infect Dis 2013; 13(179): 13179-2334
51. Suhaimi A, Dengue encephalitis. International Medical Journal (IIUM) 2002; 1(2).
52. Masliza M, Noor Darinah MD, Ibtisam M, et al. Atrial fibrillation as a complication of dengue hemorrhagic fever: non-self-limiting manifestation. Int J Infect Dis 2009; 13(5): e316-8.
53. Capeding MR, Chua MN, Hadinegoro SR, et al. Dengue and Other Common Causes of Acute Febrile Illness in Asia: An Active Surveillance Study in Children. Neglected Trop Dis 2007; 7(7): 1-9.
54. Hamidon BB, Saadiah S. Seoul hantavirus infection mimicking dengue fever. Med J Malaysia 2003; 58(5): 786-7.
55. Yong LS, Koh KC. A case of mixed infections in a patient presenting with acute febrile illness in the tropics. Case Rep Infect Dis 2013; 2013: 562175.
56. Nayar SK, Noridah O, Paranthaman V, et al. Co-infection of dengue virus and chikungunya virus in two patients with acute febrile illness. Med J Malaysia 2007; 62(4): 335-6.
57. Ng CF, Lum LC, Noor Azina I, et al. Clinicians' diagnostic practice of dengue infections. J Clin Virol 2007; 40(3): 202-6.
58. Lum LC, Goh AY, Chan PW, et al. Risk factors for hemorrhage in severe dengue infections. J Pediatr 2002; 140(5): 629-31.
59. Bandyopadhyay S, Lum LC, Kroeger A. Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever. Trop Med Int Health 2006; 11(8): 1238-55.
60. Faisal T, Taib MN, Ibrahim F. Reexamination of risk criteria in dengue patients using the self-organizing map. Med Biol Eng Comput 2010; 48(3): 293-301.
61. Faisal T, Ibrahim F, Taib MN. Analysis of significant factors for dengue infection prognosis using the self organizing map. Conf Proc IEEE Eng Med Biol Soc 2008; 2008: 5140-3.
62. Ibrahim F, Ismail NA, Taib MN, et al. Modeling of hemoglobin in dengue fever and dengue hemorrhagic fever using bioelectrical impedance. Physiol Meas 2004; 25(3): 607-15.
63. Ibrahim F, Taib MN, Abas WA, et al. A novel dengue fever (DF) and dengue haemorrhagic fever (DHF) analysis using artificial neural network (ANN). Comput Methods Programs Biomed 2005; 79(3): 273-81
64. Ibrahim F, Faisal T, Salim MI, et al. Non-invasive diagnosis of risk in dengue patients using bioelectrical impedance analysis and artificial neural network. Med Biol Eng Comput 2010; 48(11): 1141-8.
65. Thayan R, Huat TL, Lum LCS, et al. The use of two-dimension electrophoresis to identify serum biomarkers from patients with dengue haemorrhagic fever. Trans R Soc Trop Med Hyg 2009; 103(4): 413-9.
66. Thayan R, Huat TL, Lum LCS, et al. Differential expression of aldolase, alpha tubulin and thioredoxin peroxidase in peripheral blood mononuclear cells from dengue fever and dengue hemorrhagic fever patients. Southeast Asian J Trop Med Public Health 2009; 40(1): 56-65.
67. Dung N M, Day NP, Tam TH, Loan HT, Chau HTT, Minh LN, Bethell DB, Kneen R, Hien TT, White NJ, Farrar JJ. Fluid replacement in Dengue Shock Syndrome: A Randomized, Double-blind Comparison of Four Intravenous Fluid Regimens. Clinical Infectious Disease 1999; 29: 787-94.
68. Lum LCS, Abdel-Latif Mel-A, Goh AYT, et al. Preventive transfusion in Dengue shock syndrome-is it necessary? J Pediatr 2003; 143(5): 682-4.
69. Subenthiran S, Tan CC, Cheong KC, et al. Carica papaya leaves juice significantly accelerates the rate of increase in platelet count among patients with dengue fever and dengue haemorrhagic fever. Evid Based Complement Alternat Med 2013; 2013: 616737.
70. Gan CS, Chong SY, Lum LCS, et al. Regular paracetamol in severe dengue: a lethal combination? Singapore Med J 2013; 54(2): e35-7.
71. Tan SS, Bujang MA. The clinical features and outcomes of acute liver failure associated with dengue infection in adults: a case series. Braz J Infect Dis 2013; 17(2): 164-9.
72. Lim SV, Rahman MB, Tejo BA. Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus. BMC Bioinformatics 2011; 12 Suppl 13: S24, 2105-12-S13-S24. Epub 011 Nov 30.
73. Heh CH, Othman R, Buckle MJ, et al. Rational discovery of dengue type 2 non-competitive inhibitors. Chem Biol Drug Des 2013; 82(1): 1-11
74. Ang KT, Dengue cluster outbreak in Gombak. Journal of Health Management 2008; 5(2): 55-61.
75. Nasarudin NM, Mohd SI, Ismail AK. The role of an emergency department short-stay ward in the management of dengue fever: a case-control study in a university hospital. Eur J Emerg Med 2013; 20(5): 335-8
76. Sazaly AB, Shafee N. Outlook of dengue in Malaysia: a century later. Malays J Pathol 2002; 24(1): 23-7.
77. Lam SK, Challenges in reducing dengue burden; diagnostics, control measures and vaccines. Expert Rev Vaccines 2013; 12(9): 995-1010.
78. Lam SK, Burke D, Capeding MR, et al. Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting. Vaccine 2011; 29(51): 9417-22.
79. Amar Singh HSS, Koh MT, Tan KK, et al. Safety and immunogenicity of a tetravalent dengue vaccine inhealthy children aged 2-11 years in Malaysia: A randomized, placebo-controlled, Phase III study. Vaccine 2013; 31(49): 5814-21.
80. Wong SS, Abd-Jamil J, Sazaly AB. Antibody neutralization and viral virulence in recurring dengue virus type 2 outbreaks. Viral Immunol 2007; 20(3): 359-68.
81. Teoh BT, Sam SS, Juraina AJ, et al. Isolation of ancestral sylvatic dengue virus type 1, Malaysia. Emerg Infect Dis 2010; 16(11): 1783-5.
82. Cardosa MJ, Ooi MH, Tio PH, et al. Dengue virus serotype 2 from a sylvatic lineage isolated from a patient with dengue hemorrhagic fever. PLoS Negl Trop Dis 2009; 3(4): e423.
83. Norlijah O, Booth A, Intan H, et al. Overt bleeding in dengue infection. Asian-Oceanian Journal of Pediatrics and Child Health 2006; 1:23-30.
84. Lum LCS, Suaya JA, Tan LH, et al. Quality of life of dengue patients. Am J Trop Med Hyg 2008; 78(6): 862-7.
85. Suaya JA, Shepard DS, Siqueira JB, et al. Cost of dengue cases in eight countries in the Americas and Asia: a prospective study. Am J Trop Med Hyg 2009; 80(5): 846-55.
86. Lee HL, Vasan SS, Birgelen L, et al. Immediate cost of dengue to Malaysia and Thailand: an estimate. Dengue Bulletin 2010; 34: 65-76.
87. Undurraga EA, Halasa YA, Shepard DS. Use of Expansion Factors to Estimate the Burden of Dengue in Southeast Asia: A Systematic Analysis. PLoS Negl Trop Dis 2013; 7(2): e2056.
88. Shepard DS, Lees RS, Ng CW, Undurraga EA, Halasa Y, Lum LCS. Burden of Dengue in Malaysia. Report from a Collaboration between Universities and the Ministry of Health of Malaysia. 2013.
89. Withehorn J, Van Vinh Chau N, et al. Lovastatin for adults patients with dengue: protocol for a randomized controlled trial. Trial 2012 doi: 10.1186/1745-6215-13-203.
90. Capeding M R, Tran N H, et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomized, observer-masked, placebo-controlled trial. Lancet 2014 (online publication).